Limiting Evergreening for Name-Brand Prescription Drugs | Committee for a Responsible Federal Budget
A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study | BMC Pharmacology
Brand-name vs. generic drugs: Which is better?
U.S. Consumers Overpay for Generic Drugs – USC Schaeffer
FDA Approves More Generic Drugs, but Competition Still Lags | The Pew Charitable Trusts
Generic Versus Brand-Name Drugs: What's the Difference?
Competition and price among brand-name drugs in the same class: A systematic review of the evidence | PLOS Medicine
Generic Versus Brand-Name Drugs: What's the Difference?
FDA Issues Guidance for Competitive Generic Therapies - DCAT Value Chain Insights
Hatch Amendment Would Delay Generic Competition And Increase Drug Costs | Health Affairs
Market competition a predictor of changes in generic drug prices, concludes US study - The Pharmaceutical Journal
What's the Difference Between a Brand-Name Drug and a Generic Name Drug? - GoodRx
Generic Competition and Drug Prices | FDA
U.S. Consumers Overpay for Generic Drugs – USC Schaeffer
Association of Generic Competition With Price Decreases in Physician-Administered Drugs and Estimated Price Decreases for Biosimilar Competition - westhealth.org
FDA Approves More Generic Drugs, but Competition Still Lags | The Pew Charitable Trusts
Drugmakers Master Rolling Out Their Own Generics To Stifle Competition | Kaiser Health News
A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study | BMC Pharmacology
Shifts in the Generic-Drug Market: Trends and Causes
Why the US has higher drug prices than other countries
Full article: Updated trends in US brand-name and generic drug competition
Brand Name vs. Generic Drugs: Understanding the Difference
Generic Drug Facts | FDA
1 TESTIMONY BEFORE THE UNITED STATES SENATE COMMITTEE ON HEALTH, EDUCATION, LABOR, AND PENSIONS SUBCOMMITTEE ON PRIMARY HEALTH A
As competition goes down, generic drug prices rise, study finds
